A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop ...

A live-attenuated vaccine under development is safe and 100% effective against Lassa virus in preclinical studies. A vaccine candidate against Lassa virus completely protected guinea pigs exposed to ...

Please provide your email address to receive an email when new articles are posted on . Most transplant recipients developed and maintained protective antibodies up to 1 year after varicella or MMR ...

Globally, RSV is responsible for an immense health and economic burden, causing an estimated 33 million new ALRI cases and ...

Live virus vaccines use a weakened virus to help your body fight the real disease. Some people, like those who are very sick or pregnant, should not get live virus vaccines. A live virus vaccine ...

Long regarded as disease-specific, some widely used vaccines may confer broader health benefits that extend beyond protection against intended pathogens. Evidence suggests that certain live attenuated ...

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide ...